Cambridge, UK – 23 September 2024 – electronRx, a leading digital medicine and biomarker expert, is excited to announce its sponsorship of PHA Europe in support of their vision of better quality of life and finding a cure for pulmonary hypertension (PH). This collaboration builds on electronRx’s mission to transform the lives of people living with breathing conditions like PH, supporting them to make informed decisions.
As part of this sponsorship, electronRx will provide financial support, with the team fundraising and building awareness of PH at organised events. Funds will directly contribute to PHA Europe's five main areas for action; improving access to expert care, improving awareness and screening, encouraging clinical research and innovation, empowering patient groups and ensuring availability of psychosocial support.
"We are honoured to partner with PHA Europe and help improve the quality of life of patients living with PH," said Dr Bipin Patel, CEO of electronRx. "At electronRx, we are committed to helping people breathe with our simple innovative technology. Supporting those affected by breathing conditions such as PH is critical to us, our focus is on the people we’re helping. Behind every line of code and every task is a person who deserves better health and a better quality of life. Supporting associations like PHA Europe is a reflection of our values and dedication at electronRx, enabling us to make a real difference to millions of peoples lives."
Gerald Fischer, CEO of PHA Europe, expressed their appreciation, "The generous support from electronRx enhances our mission. Together, we can provide a better quality of life and find a cure for PH. We are grateful for their commitment and look forward to a fruitful partnership."
For more information about this partnership and upcoming activity, please visit electronrx.com or phaeurope.org.
